SLC27A2 and neoplasm: The GSEA results showed that the high expression group of SLC27A2 in DLBCL is mainly enriched in GO pathways, such as Fatty acid synthesis activity, Immune response to tumor cell, Mitotic DNA replication, Positive regulation of Immune response to tumor cell, and Regulation of chronic inflammatory response.